4.5 Article

Structures of CYLD USP with Met1-or Lys63-linked diubiquitin reveal mechanisms for dual specificity

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 22, Issue 3, Pages 222-229

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2970

Keywords

-

Funding

  1. CREST, JST
  2. [22121003]
  3. [22117002]
  4. [22117003]
  5. [22117006]
  6. [25117711]
  7. [25112505]
  8. [24687012]
  9. [24247014]
  10. Grants-in-Aid for Scientific Research [25650003, 22117001, 22117003, 24390079, 25670137, 24570126, 22121003, 22117006, 22117002, 26840062] Funding Source: KAKEN

Ask authors/readers for more resources

The tumor suppressor CYLD belongs to a ubiquitin (Ub)-specific protease (USP) family and specifically cleaves Met1- and Lys63-linked polyubiquitin chains to suppress inflammatory signaling pathways. Here, we report crystal structures representing the catalytic states of zebrafish CYLD for Met1- and Lys63-linked Ub chains and two distinct precatalytic states for Met1-linked chains. In both catalytic states, the distal Ub is bound to CYLD in a similar manner, and the scissile bond is located close to the catalytic residue, whereas the proximal Ub is bound in a manner specific to Met1- or Lys63-linked chains. Further structure-based mutagenesis experiments support the mechanism by which CYLD specifically cleaves both Met1- and Lys63-linked chains and provide insight into tumor-associated mutations of CYLD. This study provides new structural insight into the mechanisms by which USP family deubiquitinating enzymes recognize and cleave Ub chains with specific linkage types.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available